Celcuity (CELC) Net Cash Flow Growth (3y) (2019 - 2025)
Celcuity (CELC) Net Cash Flow Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
68.44% |
| Date | Value |
|---|
| Dec 31, 2025 |
68.44% |
| Sep 30, 2025 |
70.53% |
| Jun 30, 2025 |
66.60% |
| Mar 31, 2025 |
-0.26% |
| Dec 31, 2024 |
53.69% |
| Sep 30, 2024 |
-33.26% |
| Jun 30, 2024 |
-28.32% |
| Mar 31, 2024 |
-71.28% |
| Dec 31, 2023 |
63.64% |
| Sep 30, 2023 |
-55.17% |
| Jun 30, 2023 |
0.55% |
| Mar 31, 2023 |
89.65% |
| Dec 31, 2022 |
-148.52% |
| Sep 30, 2022 |
-107.80% |
| Jun 30, 2022 |
-293.28% |
| Mar 31, 2022 |
-69.95% |
| Dec 31, 2021 |
-35.74% |
| Sep 30, 2021 |
336.48% |
| Jun 30, 2021 |
123.52% |
| Mar 31, 2021 |
604.10% |
